Sanofi to Acquire Blueprint Medicines for $9.1B Business By Jack Mulligan Sanofi SA (NASDAQ: SNY) announced on Monday that it has agreed to acquire Blueprint Medicines Corporation (NASDAQ: BPMC) in a…
China’s Growing Influence in the U.S. Biopharma Industry Business By Jack Mulligan A little-known biotech company stunned the industry last spring when Summit Therapeutics announced its experimental cancer drug showed greater effectiveness…
Roche Joins Forces with Nvidia to Transform Drug Development Using AI Business By Lorenzo Sorvani In a groundbreaking move, Genentech, a subsidiary of Roche, has embarked on a strategic partnership with the renowned chipmaker Nvidia,…
